Published onon promotion and regulationAI + Health application development(hereinafter referred to as " implementation opinion " )。
The Implementation Opinion is divided into five parts:
- Part I contains general requirements. PresentArtificial intelligence + healthIt's not like it's the same thing. The main development goals for the years 2027 and 2030 are based on the development of infrastructure, progress in application and business development needs in the health sector。
- The second part is focused on deepening the application. This includes, inter alia, the application of artificial intelligence at the grass-roots level, clinical consultations, patient services, Chinese medicine, public health, teaching of scientific research, industry governance, health industry, etc。
- Part III provides the basis for practical application. Five areas have been proposed for strengthening infrastructure, enriching the supply of medical data, optimizing artificial intelligence algorithms, strengthening the establishment of a Chinese test base, and strengthening scientific and technological skills and standard support。
- Part IV regulates security controls. Three elements were proposed to optimize industry management and auditing systems, innovative regulatory approaches and early warning mechanisms, enhanced data security and personal privacy protection。
- Part V strengthens organizational security. Strengthen system-building, pilot demonstration and advocacy cooperation to promote win-win, win-win, smart-for-good, technology inclusive and results-sharing。
The Implementing Opinion refers to:
- By 2027, establish a set of high-quality health sector data sets and a credible data spaceForming a set of major vertical models and smart body applications for clinical specialistsAt the primary level, mental aids, specialized clinical diagnostics, decision-making and patient-to-patient intelligence services are widely used in health-care institutions, and a number of national testing sites for artificial intelligence applications in the health sector have been built, and more high-value applications have been created, leading to high-quality health-care industry development。
- By 2030, primary-level diagnostic smart-aid applications will have achieved almost full coverageTo promote the universal application of artificial intelligence technologies, such as medical video-enabled diagnostics, clinical diagnostic intelligence-aided decision-making, to hospitals above the second level, and the basic refinement of the standard system for the application of artificial intelligence + health care, building up a world-leading base for technological innovation and talent development。
THE FOCUS OF THE IT HOME, WITH THE OPINION, IS AS FOLLOWS:
(i) Artificial intelligence + grass-roots applications
1. Strengthening of the close district medical community intelligence applications。The focus is on the grass-roots level, strengthening the central role of the sharing of resources for the diagnosis of medical images, electrocardiograms, medical tests, pathological diagnostics, disinfection, etc., and improving the intelligence of services for the benefit of the population, such as diagnostic services, basic public health, the management of chronic diseases, the contracting of services by family doctors, and the provision of mental services by Chinese doctors。
2. Establishment of an intellectually assisted medical application for doctors at the grass-roots level。In the case of common and multiple diseases at the grass-roots level, use is made of low-level mental aids, which are provided to doctors at the grass-roots level in the form of auxiliary consultations, prescription reviews, follow-up management, Chinese medical treatment, etc., and the capacity of services such as general diagnostics at the basic level, diagnostics for disease identification, diagnostics for medical imaging, etc。
3. Strengthening of the management of chronic diseases in the population。The implementation of the application of smart chronic disease management and personal health portraits, the promotion of electronic health record-keeping for the population, the implementation of smart services such as screening for chronic diseases, assessment rating and individualized interventions, support for the self-health management of the population and the construction of new models of smart services for chronic disease management at the grass-roots level。
4. Strengthening health management, old-age and care services。In conjunction with the "Weight Management Year" campaign, individualized health science smart diets and sports advice are provided. :: Strengthening of services and supervision for old-age and nursing intelligence. Promotion of smart applications such as health management and day-to-day care guidance for key groups such as the elderly, maternity and children, and raising awareness of self-management of health for the entire population。
(ii) Artificial intelligence + clinical treatment
5. Promotion of smart diagnostic services for medical images。Support for the integration of the provincial integration of medical video support services, such as diagnostics, production of reports, evaluation of image quality and provision of treatment programme advice, encouraging the development of medical video support diagnostics from single cases to multiple diseases in individual organs in hospitals at the secondary level and above, and improving the efficiency and quality of video diagnosis and reporting. High-level hospitals were selected for high-quality medical image data collection and application research development to support the development and iterative upgrading of large artificial intelligence models。
6. Expansion of clinically specialized paramedical services。Promotion of the expansion of the use of smart clinical decision-making by the National Medical Centre, national and provincial regional medical centres, with a focus on the use of smart support for clinical decision-making for major suspected diseases such as paediatrics, psychiatry, tumours and rare diseases, and the enhancement of the diagnostic capacity of clinical specialists。
7. Promotion of smart rehabilitation and pharmaceutical services。Promotion of smart medical equipment such as rehabilitation robots and acupuncture robots in Chinese medicine, and full coverage of mental rehabilitation services in rehabilitation specialist hospitals and rehabilitation units in tertiary general hospitals. Development of smart pharmacies, promotion of smart applications such as prescription transfers, drug verification and pre-prescription audits。
(iii) Artificial intelligence + patient services
Optimizing patient intelligence service processes。The level II and above hospitals provide the patient with an accurate appointment and referral service, an intelligent pre-consultation, a cloud-based visit, and an intelligent follow-up service. Promotion of bedside intelligence devices, early warning of case surveillance, bedside intelligence care, etc., to improve patient access. Promote cross-regional and inter-agency recognition and sharing of inspection results. Promotion of smart services such as mobile payments, one-stop medical insurance settlement, rapid settlement of commercial insurance claims, satisfaction surveys, after-care management。
9. Strengthened smart referral services。Support is provided to the provinces for the integrated development of an intelligent referral information system, which provides a referral service based on the regional distribution of medical resources, the unit load rate and the degree of urgency of the patient ' s condition, with a reasonable allocation of resources at the primary health-care level and at level II and above。
(iv) Artificial intelligence + Chinese medicine
10. Strengthening the use of smart medical care。Focusing on real world and evidence-based medical data for clinical care in Chinese medicine, building a knowledge base on clinical expertise in Chinese medicine, producing a body of high-quality data sets, supporting the development of a large model of Chinese medicine treatment, improving the capacity of Chinese medicine to support clinical treatment and improving the level of rational use of Chinese medicine。
11. Strengthen Chinese drug-based smart management。Encourage Chinese drug research and development institutions and grow and produce companies to construct a full-process system for Chinese medicines, explore digital twinning systems for the cultivation of local medicinal products, achieve full-growth monitoring, guidance and traceability, promote digital acquisition of information on the Chinese tablet-making process, intelligence analysis and full-process smart management of Chinese drug cultivation, processing and use。
12. Advance the smart upgrading of Chinese medicine equipment。(c) Encourage local development of Chinese medical intelligence diagnostic equipment for the quantification of “four-diagnostic” data collection and analysis. To explore the use of smart devices such as acupuncture and robots. Support for the development of customized smart cooking equipment for Chinese medicines and promotion of upgrading of traditional technology。
(v) Artificial intelligence + public health
13. Strengthen early warning of infectious disease surveillance。Build a system for monitoring, early warning and disposal of the full-process closed-ring management, advance the upgrading of the smart-flow system and provide real-time, accurate support for decision-making on the control of infectious diseases. Accelerated deployment of the national early warning alert software for infectious diseases to medical institutions using the Epidemic Reporting System throughout the country. Optimizing rapid detection and smart analysis of the risks of infectious disease cases and epidemiology concentrations, abnormal change detection, etc。
Strengthening health emergency management and disposal。Strengthen the in-depth application of artificial intelligence in public health and disease prevention and control, improve early warning of public health emergencies, integrate health information data resources, monitor medical treatment and health emergency information, predict early warning health emergency risks, recommend disposal programmes and achieve smart disposal。
15. Strengthen the management of priority diseases and population groups。PROVINCIALLY, THE USE OF SMART-AIDED DIAGNOSTIC APPLICATIONS FOR PATHOLOGY, B ULTRA-RADIO-IMAGE AND EARLY DISEASE SCREENING IS PROMOTED. (B) CONDUCTING EARLY INTELLIGENCE DIAGNOSIS OF OCCUPATIONAL DISEASES AND IMPROVING THE APPLICATION OF SMART PERSONAL PROTECTION EQUIPMENT. STRENGTHENING OF INTELLIGENCE SURVEILLANCE SERVICES ON PUBLIC PSYCHOLOGICAL ISSUES, WITH A FOCUS ON STUDENTS, PROVIDING SMART SCREENING, EARLY WARNING, INTERVENTION SERVICES AND FOLLOW-UP ANALYSIS ON PSYCHOLOGICAL PROBLEMS。
(vi) Artificial intelligence + scientific teaching
16. Deepening the smart application of medical science research。The National Medical Centre, the National Centre for Clinical Medical Research and the University of Focus promote the sharing of scientific and research work in terms of literature overview, research programme generation, data collection and analysis, management of scientific and research resources, scientific data security, research wards, clinical experiments, etc。
17. Expansion of health services。Encourage the provision of personalized smart health information to the public at large and universal access to services and customized health information, as well as the provision of innovative knowledge to medical personnel in the areas of intelligent medical literature analysis, scientific problem detection, scientific and academic evaluation。
18. Promote the transformation of the results of drug research。To promote the high-quality development of the pharmaceutical industry, to encourage the development of new drug screening models and to accelerate the development of new drug intelligence, in collaboration with pharmaceutical-producing enterprises, such as the National Medical Centre, the Regional Medical Centre and the Clinical Medical Research Centre, for major diseases, as well as for rare and specific groups of people. Support local integration of Chinese medicine clinical data and Chinese drug application data, development of rapid and efficient combination drug selection models, support to Chinese drug group optimization and innovative Chinese drug development。
(vii) Artificial intelligence + industry governance
19. Promote smart management in health institutions。To strengthen the accurate analysis of medical management data, such as the quality of mental health care, medical costs and single-disease cost management, as well as the intelligent allocation of medical equipment and consumables, the intelligent management of operating theatres and pharmacies, and the smart management of hospital medical care, medical services, logistics, logistics and security。
20. Strengthening smart health sector regulation。To promote the development and governance of health care, health care, health care and co-development of medicine, and to integrate them with a view to furthering health care and intellectual empowerment. :: Conducting real-time data collection and analysis of critical information case data, achieving smart monitoring, analysis and early warning at the health resources, services, quality, safety and capability levels, and establishing provincial and regional smart-assisted decision-making systems for emergency allocation and disposal of medical resources for public emergencies。
21. Deepen the smart application of the emergency response system。Establishment of a unified national system of command for smart first aid, which will enhance the ability to respond to acute emergencies such as heart attack, brain attack and trauma. Establishment of an intelligent blood management system to enhance inventory monitoring and linkage security. Improve the early warning and tiered response system for the monitoring of drugs in short supply, and ensure that essential clinical drugs are stored on demand and reasonably allocated。
(viii) Artificial intelligence + health industry
22. Develop new and intelligent services。Promote the concept of healthy consumption and encourage the development of new services such as smart health check-ups, health counselling and health management. Support for innovative models of medical intelligence services, promotion of innovative health products, and health information advice and promotion on rational use of medicines and chronic disease management. Accelerated use of smart physiotherapy to support access to clinical trials for qualified artificial intelligence products。
23. Upgrade the innovative capacity of smart medical equipment。Support for the development of smart medical equipment up and down the industrial chain, such as joint medical facilities, research institutes, etc., in order to promote the intellectual upgrading of medical equipment in the areas of medical imagery, diagnostic testing, treatment, guardianship and life support, and to encourage joint declaration of participation in the innovative task of artificially intelligent medical devices. Support for the first (set) application of nationally produced smart medical equipment in medical institutions, with a view to promoting the use of smart medical equipment that is at the forefront of technological innovation and clinical applications in the country。
24. Promote innovation in the intelligent information industry。Strengthen research and development of artificial intelligence standard data sets and language banks, core application components, etc., to support local development of a credible data space for high-quality medical health data and to encourage the development of vertical large model applications in the health sector. Incubation of specialized, specialized medical intelligence。